Scarica l'app Stockscreener
42.03
4.17%
-1.83
Dopo l'orario di chiusura:
42.03
Precedente Chiudi:
$43.86
Aprire:
$43.18
Volume 24 ore:
849.42K
Relative Volume:
0.65
Capitalizzazione di mercato:
$3.38B
Reddito:
$541.74M
Utile/perdita netta:
$88.01M
Rapporto P/E:
38.69
EPS:
1.0862
Flusso di cassa netto:
$155.34M
1 W Prestazione:
-5.91%
1M Prestazione:
-9.16%
6M Prestazione:
+28.22%
1 anno Prestazione:
+36.37%
Intervallo 1D:
$41.64
$43.78
Intervallo di 1 settimana:
$41.57
$44.81
Portata 52W:
$29.45
$60.91
Veracyte Inc Stock (VCYT) Company Profile
Nome
Veracyte Inc
Settore
Industria
Telefono
(650) 243-6300
Indirizzo
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, NTRA, IQV, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
42.03 | 3.53B | 541.74M | 88.01M | 155.34M | 1.0862 |
TMO
Thermo Fisher Scientific Inc
|
603.18 | 223.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
200.53 | 144.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
326.14 | 47.61B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
257.30 | 42.30B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
143.12 | 40.81B | 7.23B | 1.41B | 1.09B | 4.979 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-13 | Iniziato | Jefferies | Buy |
| 2025-12-02 | Ripresa | Morgan Stanley | Underweight |
| 2025-10-20 | Iniziato | Canaccord Genuity | Hold |
| 2025-03-20 | Iniziato | Craig Hallum | Buy |
| 2024-12-05 | Downgrade | Goldman | Buy → Neutral |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-10-16 | Iniziato | UBS | Buy |
| 2024-10-10 | Iniziato | Guggenheim | Buy |
| 2024-02-23 | Reiterato | Needham | Buy |
| 2023-01-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2021-11-18 | Ripresa | Goldman | Buy |
| 2021-06-15 | Iniziato | Raymond James | Outperform |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Iniziato | Morgan Stanley | Underweight |
| 2019-07-31 | Iniziato | Lake Street | Buy |
| 2019-07-02 | Iniziato | Needham | Buy |
| 2018-11-29 | Downgrade | Janney | Buy → Neutral |
| 2018-10-31 | Aggiornamento | Janney | Neutral → Buy |
| 2017-11-07 | Downgrade | Janney | Buy → Neutral |
| 2017-11-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Ripresa | BTIG Research | Buy |
| 2016-11-14 | Ripresa | Leerink Partners | Outperform |
| 2015-12-18 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-06-11 | Reiterato | Leerink Partners | Outperform |
| 2013-11-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Veracyte Inc Borsa (VCYT) Ultime notizie
COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down - Zacks Investment Research
Zacks Industry Outlook Highlights Veracyte, Globus Medical and UFP Technologies - TradingView
Veracyte Inc (VCYT) Shares Surge 3.3% -- What GF Score of 81 Tel - GuruFocus
VCYT Maintains Buy Rating by UBS -- Price Target Raised to $65 - GuruFocus
UBS Adjusts Price Target on Veracyte to $65 From $52, Keeps Buy Rating - marketscreener.com
Veracyte CFO Rebecca Chambers Forfeits 3,603 Shares at $44.88 and Sells Additional Shares in Early September - Kalkine Media
VERACYTE Executive Leite John Forfeits 3,961 Shares at $44.88 Each (NASDAQ: VCYT) - Kalkine Media
Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline - Eastern Progress
Chief Scientific & Medical Officer Of Veracyte Sold 33% Of Their Shares - simplywall.st
Veracyte CFO Rebecca Chambers sells $157,394 in VCYT shares By Investing.com - Investing.com Australia
Veracyte EVP, general counsel Annie McGuire sells over $140,000 in stock By Investing.com - Investing.com South Africa
Veracyte chief scientific & med officer sells over $564k stock - Investing.com Nigeria
Veracyte EVP, general counsel Annie McGuire sells over $140,000 in stock - Investing.com Nigeria
Veracyte chief scientific & med officer sells over $564k stock By Investing.com - Investing.com South Africa
Veracyte CFO Rebecca Chambers sells $157,394 in VCYT shares - Investing.com India
Veracyte (VCYT) CFO stock sale alongside tax share withholding - Stock Titan
Veracyte Inc (VCYT) Shares Fall 4.8% -- GF Value Says Still Over - GuruFocus
VCYT News | VERACYTE INC (NASDAQ:VCYT) - ChartMill
Veracyte (NASDAQ: VCYT) CAO has RSU shares withheld for taxes - Stock Titan
Veracyte (VCYT) insider sells 13,110 shares under pre-set plan - Stock Titan
Veracyte (VCYT) CCO logs tax withholding, not sale - Stock Titan
Veracyte (VCYT) CEO holds 432,073 shares after tax withholding - Stock Titan
Veracyte (NASDAQ: VCYT) officer lines up 3,254-share stock sale - Stock Titan
Veracyte (NASDAQ: VCYT) officer to sell 3,652 shares - Stock Titan
Officer plans stock sale in Veracyte (NASDAQ: VCYT) - Stock Titan
Veracyte (VCYT) Director Muna Bhanji Sells 1,864 Shares - GuruFocus
Veracyte (VCYT) director sells 1,864 shares in pre-planned trade - Stock Titan
The Technical Signals Behind (VCYT) That Institutions Follow - news.stocktradersdaily.com
Muna Bhanji plans sale of 3,728 Veracyte (NASDAQ: VCYT) shares - Stock Titan
Veracyte Inc. (VCYT) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Cathie Wood’s ARK sells Tempus AI stock, buys Veracyte By Investing.com - Investing.com Nigeria
Veracyte (VCYT) Institutional Ownership 2026 $VCYT - MarketBeat
Is it Worth Adding Veracyte Stock to Your Portfolio Now? - Yahoo Finance
VCYT Drops 25.3% in the Past Month. Is the Sell-Off an Opportunity? - TradingView
Virtus Advisers LLC Purchases New Shares in Veracyte, Inc. $VCYT - MarketBeat
Great Lakes Advisors LLC Invests $3.85 Million in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (VCYT): Moves 0.50% Down to $41.98 on the Day; Trading Range: the Price Remains Bounded by the Supplied Support and ResistanceDividend Arbitrage - vinanet.vn
Lisanti Capital Growth LLC Purchases Shares of 63,400 Veracyte, Inc. $VCYT - MarketBeat
Top 3 Health Care Stocks That Could Blast Off This Month - Benzinga
Summit Creek Advisors LLC Takes Position in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (VCYT) Results at a Glance: EPS Clears the Reported Estimate in Latest Trading; Stock Move: Shares Move Lower 2.50%Investor Earnings Call - vinanet.vn
Rice Hall James & Associates LLC Invests $5.61 Million in Veracyte, Inc. $VCYT - MarketBeat
Veracyte Inc (VCYT) News, Articles, Events & Latest Updates - Stocktwits
Down 30.2% in 4 Weeks, Here's Why Veracyte (VCYT) Looks Ripe for a Turnaround - Yahoo Finance
Is Veracyte (VCYT) Undervalued As Raised 2026 Outlook And Q2 Earnings Lift Interest? - Sahm
Veracyte Inc (VCYT) Shares Fall 3.2% -- GF Value Says Still Over - GuruFocus
Veracyte Debuts Prosigna Breast Test in the U.S. - Medical Product Outsourcing
Zacks Research Upgrades Veracyte (NASDAQ:VCYT) to Strong-Buy - MarketBeat
Bank of America Corp DE Grows Stock Position in Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. (VCYT) Stock Forecasts - Yahoo Finance
A Look at Veracyte Inc (VCYT) After 3.7% Decline -- GF Value $38 - GuruFocus
Veracyte Inc Azioni (VCYT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):